These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12766517)

  • 1. Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness.
    Essebag V; Eisenberg MJ
    Card Electrophysiol Rev; 2003 Jan; 7(1):43-8. PubMed ID: 12766517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II).
    Gandjour A; Holler A; Dipl-Ges-Ök ; Adarkwah CC
    Value Health; 2011; 14(6):812-7. PubMed ID: 21914500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial.
    Sharma PP; Greenlee RT; Anderson KP; Chyou PH; Osorio HJ; Smith PN; Hayes JH; Vidaillet H
    J Interv Card Electrophysiol; 2007 Sep; 19(3):157-64. PubMed ID: 17805953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The impact of the Multicenter Automatic Defibrillator Implantation Trial II in a university hospital--do all patients with myocardial infarction and reduced left ventricular function need an implantable cardioverter-defibrillator?].
    Lercher P; Rotman B; Scherr D; Kraxner W; Luha O; Klein W
    Wien Klin Wochenschr; 2003 Mar; 115(5-6):167-74. PubMed ID: 12741076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.
    Al-Khatib SM; Anstrom KJ; Eisenstein EL; Peterson ED; Jollis JG; Mark DB; Li Y; O'Connor CM; Shaw LK; Califf RM
    Ann Intern Med; 2005 Apr; 142(8):593-600. PubMed ID: 15838065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Zwanziger J; Hall WJ; Dick AW; Zhao H; Mushlin AI; Hahn RM; Wang H; Andrews ML; Mooney C; Wang H; Moss AJ
    J Am Coll Cardiol; 2006 Jun; 47(11):2310-8. PubMed ID: 16750701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients?
    Tanno K; Miyoshi F; Watanabe N; Minoura Y; Kawamura M; Ryu S; Asano T; Kobayashi Y; Katagiri T;
    Circ J; 2005 Jan; 69(1):19-22. PubMed ID: 15635196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials.
    Katritsis DG; Siontis KC; Bigger JT; Kadish AH; Steinman R; Zareba W; Siontis GC; Bardy GH; Ioannidis JP
    Heart Rhythm; 2013 Feb; 10(2):200-6. PubMed ID: 23107652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
    Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK
    Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
    Block M; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?
    Siu CW; Pong V; Ho HH; Liu S; Lau CP; Li SW; Tse HF
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):231-5. PubMed ID: 19804551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insufficient compliance with current implantable cardioverter defibrillator (ICD) therapy guidelines in post myocardial infarction patients is associated with increased mortality.
    Pertzov B; Novack V; Zahger D; Katz A; Amit G
    Int J Cardiol; 2013 Jun; 166(2):421-4. PubMed ID: 22100182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
    Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing specificity without sacrificing sensitivity: potential benefits of using microvolt T-wave alternans testing to risk stratify the MADIT-II population.
    Cohen RJ
    Card Electrophysiol Rev; 2003 Dec; 7(4):438-42. PubMed ID: 15071271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction.
    Yap YG; Duong T; Bland JM; Malik M; Torp-Pedersen C; Køber L; Gallagher MM; Camm AJ
    Heart; 2007 Jul; 93(7):832-6. PubMed ID: 17237132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.